85 related articles for article (PubMed ID: 25202086)
1. Proteomic identification of dihydrolipoamide dehydrogenase as a target of autoantibodies in patients with endometrial cancer.
Yoneyama K; Shibata R; Igarashi A; Kojima S; Kodani Y; Nagata K; Kurose K; Kawase R; Takeshita T; Hattori S
Anticancer Res; 2014 Sep; 34(9):5021-7. PubMed ID: 25202086
[TBL] [Abstract][Full Text] [Related]
2. Proteomic identification of autoantibodies in sera from patients with ovarian cancer as possible diagnostic biomarkers.
Yoneyama K; Kojima S; Kodani Y; Yamaguchi N; Igarashi A; Kurose K; Kawase R; Takeshita T; Hattori S; Nagata K
Anticancer Res; 2015 Feb; 35(2):881-9. PubMed ID: 25667470
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function.
Van de Water J; Fregeau D; Davis P; Ansari A; Danner D; Leung P; Coppel R; Gershwin ME
J Immunol; 1988 Oct; 141(7):2321-4. PubMed ID: 3049806
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody against dihydrolipoamide dehydrogenase, the E3 subunit of the 2-oxoacid dehydrogenase complexes: significance for primary biliary cirrhosis.
Maeda T; Loveland BE; Rowley MJ; Mackay IR
Hepatology; 1991 Dec; 14(6):994-9. PubMed ID: 1959888
[TBL] [Abstract][Full Text] [Related]
5. Epitope recognition by anti-cathepsin D autoantibodies in endometrial cancer patients.
Bosscher JR; Gerçel-Taylor C; Watkins CS; Taylor DD
Gynecol Oncol; 2001 May; 81(2):138-43. PubMed ID: 11330940
[TBL] [Abstract][Full Text] [Related]
6. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease.
Roggenbuck D; Hausdorf G; Martinez-Gamboa L; Reinhold D; Büttner T; Jungblut PR; Porstmann T; Laass MW; Henker J; Büning C; Feist E; Conrad K
Gut; 2009 Dec; 58(12):1620-8. PubMed ID: 19549613
[TBL] [Abstract][Full Text] [Related]
7. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
[TBL] [Abstract][Full Text] [Related]
8. Is there a general autoantibody signature for cancer?
Ludwig N; Keller A; Leidinger P; Harz C; Backes C; Lenhof HP; Meese E
Eur J Cancer; 2012 Oct; 48(15):2451-61. PubMed ID: 22364731
[TBL] [Abstract][Full Text] [Related]
9. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis.
Dubel L; Tanaka A; Leung PS; Van de Water J; Coppel R; Roche T; Johanet C; Motokawa Y; Ansari A; Gershwin ME
Hepatology; 1999 Apr; 29(4):1013-8. PubMed ID: 10094940
[TBL] [Abstract][Full Text] [Related]
10. Natural and disease associated autoantibodies to the autoantigen, dihydrolipoamide acetyltransferase, recognise different epitopes.
Chen QY; Mackay IR; Fida S; Myers MA; Rowley MJ
J Autoimmun; 1998 Apr; 11(2):151-61. PubMed ID: 9650094
[TBL] [Abstract][Full Text] [Related]
11. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
[TBL] [Abstract][Full Text] [Related]
12. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
13. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Miyamoto Y; Hiramatsu M; Mabuchi H; Miyamoto A; Shimizu A; Takubo T; Tanigawa N
Cancer Lett; 2008 May; 263(2):280-90. PubMed ID: 18334280
[TBL] [Abstract][Full Text] [Related]
14. Frequent immune responses to a cancer/testis antigen, CAGE, in patients with microsatellite instability-positive endometrial cancer.
Iwata T; Fujita T; Hirao N; Matsuzaki Y; Okada T; Mochimaru H; Susumu N; Matsumoto E; Sugano K; Yamashita N; Nozawa S; Kawakami Y
Clin Cancer Res; 2005 May; 11(10):3949-57. PubMed ID: 15897597
[TBL] [Abstract][Full Text] [Related]
15. Proteomics-based identification of autoantibodies in the sera of healthy Chinese individuals from Beijing.
Li WH; Zhao J; Li HY; Liu H; Li AL; Wang HX; Wang J; He K; Liang B; Yu M; Shen BF; Zhang XM
Proteomics; 2006 Sep; 6(17):4781-9. PubMed ID: 16878294
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease.
Roggenbuck D; Reinhold D; Wex T; Goihl A; von Arnim U; Malfertheiner P; Büttner T; Porstmann T; Porstmann S; Liedvogel B; Bogdanos DP; Laass MW; Conrad K
Clin Chim Acta; 2011 Apr; 412(9-10):718-24. PubMed ID: 21195704
[TBL] [Abstract][Full Text] [Related]
17. Serum-autoantibodies for discovery of prostate cancer specific biomarkers.
Massoner P; Lueking A; Goehler H; Höpfner A; Kowald A; Kugler KG; Amersdorfer P; Horninger W; Bartsch G; Schulz-Knappe P; Klocker H
Prostate; 2012 Mar; 72(4):427-36. PubMed ID: 22012634
[TBL] [Abstract][Full Text] [Related]
18. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer.
He P; Naka T; Serada S; Fujimoto M; Tanaka T; Hashimoto S; Shima Y; Yamadori T; Suzuki H; Hirashima T; Matsui K; Shiono H; Okumura M; Nishida T; Tachibana I; Norioka N; Norioka S; Kawase I
Cancer Sci; 2007 Aug; 98(8):1234-40. PubMed ID: 17506794
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
[TBL] [Abstract][Full Text] [Related]
20. Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid.
Natsuga K; Nishie W; Shinkuma S; Moriuchi R; Shibata M; Nishimura M; Hashimoto T; Shimizu H
Br J Dermatol; 2010 Mar; 162(3):513-7. PubMed ID: 19751242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
